Short answer
Autolus Therapeutics plc (AUTL) filed an 8-K current report with the SEC on August 3, 2026 reporting Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Press release updates 2026 net product revenue guidance for AUCATZYL®.
Autolus Therapeutics plc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Press release updates 2026 net product revenue guidance for AUCATZYL®
- Anticipated Q2 2026 AUCATZYL net product revenue disclosed
- First-half 2026 anticipated AUCATZYL gross margin percentage disclosed
- New credit facility and cash runway position announced as financing indicators
Item 8.01 · Other Events
- 2026 AUCATZYL net revenue guidance raised to $140 million to $150 million from $120 million to $135 million
- Guidance implies stronger commercial uptake and raises near-term revenue expectations
- Cash, equivalents and marketable securities expected to fund operations into Q2 2028
- Cash runway depends on anticipated AUCATZYL revenue and credit-facility proceeds
- Outlook remains exposed to commercialization, regulatory, manufacturing and clinical-development risks
Item EX-99.1 · Exhibit EX-99.1
- Preliminary Q2 AUCATZYL net revenue approximately $45 million, up approximately 70% versus Q1 2026 and more than 100% year over year
- FY2026 sales guidance raised to $140 million-$150 million from $120 million-$135 million, signaling stronger commercial uptake
- Gross margin approximately 35% year-to-date, reversing from approximately negative 20% in H2 2025
- $75 million funded under a five-year, interest-only facility, with total borrowing capacity up to $250 million
- Facility priced at one-month SOFR, subject to a 3.50% floor, plus 7.25%, with warrants for 3.5 million ADSs at $1.9314 each
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Autolus Therapeutics plc 8-K filings
Get the next AUTL 8-K as it lands
Follow AUTL for push alerts, or ask the research agent what this filing means.